Market Cap: $224.21M
Market Cap: $224.21M
Open
$1.06
Prev. Close
$0.3125
High
$1.09
Low
$0.9901
Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure.
Echo IQ Limited trades on the Australian Securities Exchange under the ticker EIQ.AX, priced in AUD.
Echo IQ Limited has a market capitalisation of A$340.8M, based on its latest share price.
Over the past 52 weeks EIQ.AX has traded between A$0.225 and A$1.88.
No. Echo IQ Limited does not currently pay a dividend.
Not yet. Echo IQ Limited is an exploration-stage company, so losses are expected while it develops its projects. Cash covers roughly 10 months of spending at the current burn rate, so a capital raise may be needed.
Dustin Haines is the CEO of Echo IQ Limited, which is headquartered in Sydney.
Generated automatically from reported financial data. General information only, not financial advice.